Phimosis: A rare complication of immunotherapy with durvalumab

We present a case of a 69 year old man with phimosis associated with immunotherapy with durvalumab for metastatic non-small-cell lung cancer. The patient developed vitiligo like dermatosis after the induction dose of durvalumab, subsequent administration of the immunotherapy the patient developed a...

Full description

Saved in:
Bibliographic Details
Published inUrology case reports Vol. 33; p. 101350
Main Authors Vázquez-Lavista, Luis Gabriel, Llorente, Luis, Alatorre-Alexander, Jorge, Ramírez-Muciño, José Arturo
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.11.2020
Elsevier
Subjects
Durvalumab
Immunotherapy
Oncology
Phimosis
Vitiligo
Vitiligo
Durvalumab
Phimosis
Immunotherapy
Online AccessGet full text

Cover

More Information
Summary:We present a case of a 69 year old man with phimosis associated with immunotherapy with durvalumab for metastatic non-small-cell lung cancer. The patient developed vitiligo like dermatosis after the induction dose of durvalumab, subsequent administration of the immunotherapy the patient developed a fibrous ring of the foreskin. Immune-mediated adverse reactions have been described after the use of durvalumab, but, to our knowledge, there are no reports of phimosis and vitiligo like reactions.
ISSN:2214-4420
2214-4420
DOI:10.1016/j.eucr.2020.101350